-
公开(公告)号：EP1624869B1
公开(公告)日：2012-07-04
申请号：EP04741525.2
申请日：2004-05-07
申请人： Nycomed GmbH
发明人： ANSTETT-KLEIN, Isabel , DIETRICH, Rango , NEY, Hartmut , SCHILLER, Marc , SCHÄFER-PREUSS, Sabine , HARTMANN, Manfred
CPC分类号： A61K9/2886 , A61K9/2081 , A61K9/5078 , A61K31/44 , A61K31/4439
摘要： Dosage forms for oral administration of the magnesium salt of pantoprazole are described.
-
2.发明授权RAPIDLY DISINTEGRATING TABLET COMPRISING AN ACID-LABILE ACTIVE INGREDIENT 有权用酸不稳定的活性FAST DECAY END TABLET
公开(公告)号：EP1341528B1
公开(公告)日：2012-01-18
申请号：EP01999360.9
申请日：2001-12-06
申请人： Nycomed GmbH
发明人： DIETRICH, Rango , LINDER, Rudolf , NEY, Hartmut
CPC分类号： A61K9/2081 , A61K9/1617 , A61K31/4439
摘要： A rapidly disintegrating tablet for oral administration of acid-labile active ingredients is described. The rapidly disintegrating tablet for oral administration of an acid-labile active ingredient comprises a plurality of individual active ingredient units together with pharmaceutical excipients, where the acid-labile active ingredient is present in the individual active ingredient units in a matrix composed of a mixture comprising at least one solid paraffin and one or more substances from the group of fatty alcohol, triglyceride and fatty acid ester, and where excipients which, on oral intake of the tablet, bring about rapid disintegration of the tablet are present.
-
公开(公告)号：EP1915301B1
公开(公告)日：2009-08-12
申请号：EP06763586.2
申请日：2006-06-08
申请人： Nycomed GmbH
CPC分类号： A61M15/009 , A61M2205/3569 , A61M2205/60 , B65D83/75 , B65D2203/10
摘要： The present invention relates to an aerosol container (4) with an RFID unit (2) applied to a spacer (5) connencted to the base of the aerosol container.
-
公开(公告)号：EP1894138A1
公开(公告)日：2008-03-05
申请号：EP06763584.7
申请日：2006-06-08
申请人： Nycomed GmbH
发明人： DIETRICH, Rango
CPC分类号： G06K7/10435 , G06K7/0008 , G06K19/04 , G06K19/0723
摘要： The present invention relates to a method for the provision of clinical trial products in the context of clinical trials.
摘要翻译： 本发明涉及在临床试验的背景下提供临床试验产品的方法。
-
5.发明授权
公开(公告)号：EP1341523B1
公开(公告)日：2013-01-23
申请号：EP01985365.4
申请日：2001-12-05
申请人： Nycomed GmbH
发明人： DIETRICH, Rango , LINDER, Rudolf
CPC分类号： A61K9/0095 , A61K9/1617 , A61K31/4439
-
6.发明授权DOSAGE FORM CONTAINING (S)-PANTOPRAZOLE AS ACTIVE INGREDIENT 有权PHARMACEUTICAL形成含有（S）-pantoprazole作为活性成分的
公开(公告)号：EP1624870B1
公开(公告)日：2012-08-08
申请号：EP04741526.0
申请日：2004-05-07
申请人： Nycomed GmbH
发明人： ANSTETT-KLEIN, Isabel , DIETRICH, Rango , HARTMANN, Manfred , NEY, Hartmut , SCHÄFER-PREUSS, Sabine , SCHILLER, Marc
CPC分类号： A61K9/2886 , A61K9/2081 , A61K9/2846 , A61K9/5073 , A61K9/5078 , A61K31/4439
摘要： Dosage forms for oral administration of the magnesium salt of (S)-pantoprazole are described.
-
公开(公告)号：EP1894139A1
公开(公告)日：2008-03-05
申请号：EP06763593.8
申请日：2006-06-08
申请人： Nycomed GmbH
CPC分类号： G06K7/10435 , G06K7/0008 , G06K19/04 , G06K19/0723
摘要： The present invention relates to a method for the provision of clinical trial products and packaging of clinical trial products using RFID units in the context of clinical trials.
-
8.发明授权ORAL DOSAGE FORM CONTAINING A PDE 4 INHIBITOR AS AN ACTIVE INGREDIENT AND POLYVINYLPYRROLIDON AS EXCIPIENT 有权口服药物剂型包含PDE-4抑制剂主动和聚乙烯醇不是帮助FUEL
公开(公告)号：EP1478399B1
公开(公告)日：2012-03-21
申请号：EP03704652.1
申请日：2003-02-19
申请人： Nycomed GmbH
发明人： DIETRICH, Rango , EISTETTER, Klaus , NEY, Hartmut
IPC分类号： A61K45/06 , A61K9/20 , A61K31/166 , A61K31/44 , A61P11/06
CPC分类号： A61K9/0002 , A61K9/0053 , A61K9/20 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2054 , A61K9/2059 , A61K31/166 , A61K31/44
摘要： Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
-
9.发明授权
公开(公告)号：EP1341524B1
公开(公告)日：2011-10-19
申请号：EP01991781.4
申请日：2001-12-05
申请人： Nycomed GmbH
发明人： DIETRICH, Rango , LINDER, Rudolf
IPC分类号： A61K9/16 , A61K31/4439
CPC分类号： A61K31/4439 , A61K9/0056 , A61K9/06 , A61K9/1617 , A61K9/5015
摘要： The present invention relates to the field of pharmaceutical technology and describes a pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient, in particular an acid-labile proton pump inhibitor. The invention also relates to processes for producing the paste. The paste is particularly suitable for administering acid-labile active ingredients to animals or to people who have difficulty taking solid dosage forms such as tablets or capsules.
-
公开(公告)号：EP1341527B1
公开(公告)日：2011-08-10
申请号：EP01999359.1
申请日：2001-12-06
申请人： Nycomed GmbH
发明人： DIETRICH, Rango , LINDER, Rudolf , NEY, Hartmut
CPC分类号： A61K9/2081 , A61K9/1617 , A61K9/4858 , A61K31/4439
摘要： The present invention relates to the field of pharmaceutical technology and describes a novel advantageous preparation for an active ingredient. The novel preparation is suitable for producing a large number of pharmaceutical dosage forms. In the new preparation an active ingredient is present essentially uniformly dispersed in an excipient matrix composed of one or more excipients selected from the group of fatty alcohol, triglyceride, partial glyceride and fatty acid ester.
-
-
-
-
-
-
-
-
-
搜索结果
12 条记录 (耗时 0.012 秒)
